By slowing down digestion and promoting a feeling of fullness, semaglutide reduces food intake, aiding in weight loss
The drug should emerge as a first-line therapy for persons with type 2 diabetes and associated overweight/obesity as well as atherosclerotic cardiovascular disease
NAION is a serious eye condition that can result in sudden vision loss
She is now VP of Behavioural Science at Numan, one of the major online providers of weight loss medications (pretty much everyone I know whos on a GLP1, got them from Numan)
Here are specific, tested approaches organized by the underlying cause
The best medication is the one you can access, afford, tolerate, and stay on consistently